Havells-India (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Listing of 50,421 equity shares of Havells India Ltd issued under Employee Stock Purchase Schemes 2022 and 2016, effective November 25, … | |||||||||||||||
Listing of 50,421 equity shares of Havells India Ltd issued under Employee Stock Purchase Schemes 2022 and 2016, effective November 25, 2025.
| |||||||||||||||
BSE lists 50,421 new equity shares of Havells India Ltd issued under Employee Stock Purchase Schemes 2022 and 2016, effective November 25, … | |||||||||||||||
BSE lists 50,421 new equity shares of Havells India Ltd issued under Employee Stock Purchase Schemes 2022 and 2016, effective November 25, 2025.
| |||||||||||||||
BSE announces listing of 50,421 new equity shares of Havells India Ltd allotted under Employee Stock Purchase Schemes 2022 and 2016, … | |||||||||||||||
BSE announces listing of 50,421 new equity shares of Havells India Ltd allotted under Employee Stock Purchase Schemes 2022 and 2016, effective November 25, 2025.
| |||||||||||||||
SEBI issues Certificate of Completion for recovery proceedings under RC No. 746/2015 against Bela H. Kayastha in matters involving Aarti … | |||||||||||||||
SEBI issues Certificate of Completion for recovery proceedings under RC No. 746/2015 against Bela H. Kayastha in matters involving Aarti Industries Ltd., Aarti Drugs Ltd., Havells India Ltd., Lyka Labs Ltd., and Tasc Pharmaceuticals.
| |||||||||||||||
Release Order dated November 21, 2025 issued under RC No. 746 of 2015 drawn against Bela H. Kayastha SEBI releases Recovery Certificate No. 746 of 2015 against Bela H. Kayastha in the matter involving Aarti Industries Ltd., Aarti Drugs Ltd., … | |||||||||||||||
SEBI releases Recovery Certificate No. 746 of 2015 against Bela H. Kayastha in the matter involving Aarti Industries Ltd., Aarti Drugs Ltd., Havells India Ltd., Lyka Labs Ltd. and Tasc Pharmaceuticals.
| |||||||||||||||